Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Horizons in cancer research [[electronic resource] ] . Volume 42 / / Hiroto S. Watanabe, editor
| Horizons in cancer research [[electronic resource] ] . Volume 42 / / Hiroto S. Watanabe, editor |
| Pubbl/distr/stampa | New York, : Nova Science, c2011 |
| Descrizione fisica | 1 online resource (236 p.) |
| Disciplina | 616.994 |
| Altri autori (Persone) | WatanabeHiroto S |
| Collana | Horizons in cancer research |
| Soggetto topico |
Cancer - Research
Cancer - Treatment |
| Soggetto genere / forma | Electronic books. |
| ISBN | 1-61761-378-9 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910465752703321 |
| New York, : Nova Science, c2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Horizons in cancer research [[electronic resource] ] . Volume 42 / / Hiroto S. Watanabe, editor
| Horizons in cancer research [[electronic resource] ] . Volume 42 / / Hiroto S. Watanabe, editor |
| Pubbl/distr/stampa | New York, : Nova Science, c2011 |
| Descrizione fisica | 1 online resource (236 p.) |
| Disciplina | 616.994 |
| Altri autori (Persone) | WatanabeHiroto S |
| Collana | Horizons in cancer research |
| Soggetto topico |
Cancer - Research
Cancer - Treatment |
| ISBN | 1-61761-378-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910791741303321 |
| New York, : Nova Science, c2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Horizons in cancer research . Volume 42 / / Hiroto S. Watanabe, editor
| Horizons in cancer research . Volume 42 / / Hiroto S. Watanabe, editor |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | New York, : Nova Science, c2011 |
| Descrizione fisica | 1 online resource (236 p.) |
| Disciplina | 616.994 |
| Altri autori (Persone) | WatanabeHiroto S |
| Collana | Horizons in cancer research |
| Soggetto topico |
Cancer - Research
Cancer - Treatment |
| ISBN | 1-61761-378-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- HORIZONS IN CANCER RESEARCH. VOLUME 42 -- HORIZONS IN CANCER RESEARCH. VOLUME 42 -- Library of Congress Cataloging-in-Publication Data -- Contents -- Preface -- Chapter I Signaling Pathways as Biomarkers in Human Renal Cell Carcinoma -- Summary -- Introduction -- Notch Signaling Pathway -- P53 Signaling Pathway -- HIF Signaling Pathway -- VEGF/R Signaling Pathway -- EGFR Signaling Pathway -- Carbonic Anhydrase 9 -- Fumarate Hydratase -- GLUT Transporters -- Crosstalk between Notch Pathway and HIF Signaling -- Crosstalk between Notch Pathway and EGFR Signaling -- Crosstalk between Notch Pathway and VEGF Signaling -- Crosstalk of Notch Pathway with P53 Signaling -- Conclusion -- Acknowledgments -- References -- Chapter II Role of Prostate-Specific Antigen (PSA) in Pathological Angiogenesis and Prostate Tumor Growth -- Abstract -- Conclusion -- Acknowledgments -- References -- Chapter III Elapsed Times in the Management of Early Stage Breast Cancer -- Abstract -- Introduction -- Do longer elapsed times impact breast cancer outcomes? -- Detection to Treatment -- Detection to Diagnosis -- Detection to Surgery -- Surgery to Chemotherapy -- Surgery to Radiotherapy -- Summary & -- Caveats -- What are the predictors of longer elapsed times in Canada? -- Detection to Diagnosis -- Detection to Surgery -- Surgery to Chemotherapy -- Surgery to Radiotherapy -- Summary & -- Caveats -- A multi-interval multi-resolution analytics framework -- Conclusions -- Acknowledgments -- References -- Chapter IV Positional Cloning of Tumor Suppressor Genes from 3p21.3 Involved in Major Human Cancers -- 1. Abstract -- 2. Introduction -- 3. Results -- a) Localization of Critical Regions on the Short Arm of Chromosome 3 Using Allelotyping of the Dense Set of Polymorphic Markers.
Multiple interstitial deletions were found in prevalence to terminal deletions in 3p in five epithelial tumor types -- Chromosome 3p "hot spots" affected in major epithelial tumors -- Contribution of amplification events in allelic alterations of 3p microsatellites -- Correlation of 3p allelic alterations with tumor progression -- b) Careful Mapping of LUCA and AP20 Regions Using Real Time Quantitative PCR -- QPCR for detection copy number changes -- QPCR results for RCC, BC and SCLC tumor samples and cell lines -- Comparison of LOH and QPCR data. fine deletion mapping of homozygous deletions -- Complex 3p rearrangements in major epithelial cancers -- c) NotI-Microarrays to Identify Cancer Causing Genes and Develop Biomarkers for Early Diagnosis, Prognosis and Prediction of Major Types of Cancer -- d) Identification of Novel Tumor Suppressor Genes -- Conclusion -- Acknowledgments -- References -- Chapter V Novel Methylation-Dependent Markers/Tumor Suppressor Genes Involved in the Development of Renal Cell Cancer -- Abstract -- Introduction -- RCC Methylation Profiles of RASSF1A, SEMA3B, RARbeta2, RHOA, GPX1, USP4 Genes -- Genes in the LUCA Critical Region (3p21.31) -- Genes in a Novel 3p21.3 MECA3 Region (3р21.31) -- Genes from the Distal 3p Region (3p26-P22) -- RCC Specific Methylation Profile for Six 3p Genes -- Methylation Pattern of RASSF1A, RAR-Beta2, SEMA3B, GPX1 and Tumor Progression -- Expression Profiles of Cancer Associated Genes: RBSP3, SEMA3B, SEMA3F, NPRL2, HYAL1, HYAL2, ITGA9, VILL, CHL1, and ACY1 in RCC -- High Mutation Frequency of the Tumor Suppressors RASSF1 and RBSP3 (CTDSPL) in RCC -- NotI Microarrays for Identification of RCC Biomarkers -- Conclusion -- Acknowledgments -- References -- Chapter VI Human Papillomaviruses (HPVs), Genomic Instability and the DNA Damage Response -- Abstract -- Human Papillomaviruses and Cancer. The Role of HPV Oncoproteins in the Viral Life Cycle -- Disruption of G1/S-Cell Cycle Checkpoint Regulation by High-Risk HPV Oncoproteins -- The Role of High-Risk HPV Oncoproteins in Genomic Instability and Cancer -- The Cellular DNA Damage Response -- DNA Damage -- ATM and ATR DNA Damage Checkpoint Kinases -- Downstream Targets of ATM and ATR -- The Fanconi Anemia (FA) Pathway -- DNA Repair Mechanisms -- High-Risk HPV Oncoproteins and the DNA Damage Response -- High-Risk HPV Oncoproteins Stimulate DNA Damage -- High-Risk HPV E7 Expression Triggers a Host Cell DNA Damage Checkpoint Response -- Interactions between High-Risk HPV Oncoproteins and the DNA Damage Response Machinery -- How Does the High-Risk HPV E7 Oncoprotein Induce DNA Damage and DNA Damage Checkpoint Activation? -- Advantages and Disadvantages of Interference with the Host Cell DNA Damage Response by HPV Oncoproteins -- Exploitation of the DNA Damage Response and the Viral Life Cycle -- Abrogation of the DNA Damage Response -- Future Directions -- Acknowledgments -- References -- Chapter VII Prophylactic Cranial Irradiation in Non-Small Cell Lung Cancer -- Abstract -- Introduction -- Factors Associated with Brain Metastases -- 1. Chemotherapy -- 2. Stage -- 3. Histology and Age -- Treatment of Brain Metastases -- PCI in Patients with NSCLC (Table 2) -- 1. Nonrandomized Study of PCI -- 2. Randomized Stuies of PCI -- Toxicity of PCI -- PCI: When and How? -- Conclusion -- References -- Chapter VIII Importance of Cell Cycle Regulatory Proteins and Proliferation Markers in Conventional Renal Cell Carcinoma -- Abstract -- Introduction -- Methods -- Results -- Conclusion -- Introduction -- Materials and Methods -- Patient Groups -- Tissue Sampling and Immunohistochemistry -- Sample Scoring and Statistical Analysis -- Results -- Conclusion -- References. Chapter IX Overview of Kidney Cancer: Symptoms, Diagnosis, and Treatments -- Signs and Symptoms -- Diagnosis -- Treatments -- References -- Index. |
| Record Nr. | UNINA-9910822029703321 |
| New York, : Nova Science, c2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Hormone related cancer mechanistic and nanomedicines : challenges and prospects / / Mahfoozur Rahman [and four others]
| Hormone related cancer mechanistic and nanomedicines : challenges and prospects / / Mahfoozur Rahman [and four others] |
| Edizione | [1st ed. 2022.] |
| Pubbl/distr/stampa | Singapore : , : Springer, , [2023] |
| Descrizione fisica | 1 online resource (355 pages) |
| Disciplina | 616.994071 |
| Soggetto topico |
Cancer - Endocrine aspects
Cancer - Treatment |
| ISBN | 981-19-5558-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1. Conventional Treatment Approaches in Hormonal Cancer Treatment and Challenges -- Chapter 2. Concept of Nanomedicine in Endocrine Hormone Cancer Treatment -- Chapter 3. Progress of Cancer Nanomedicine, Clinical Hurdles and Opportunities -- Chapter 4. Emergence of Nanohybrids in Hormonal Cancer Targeted Therapy -- Chapter 5. Conventional to Nanoscale-Based Carrier System in Management of Ovarian Cancer -- Chapter 6. Pancreatic Cancer Nanoparticles Targeted Therapy via Epidermal Growth Factor Receptor -- Chapter 7. Nanocarriers Based Targeted Therapies for Pancreatic Cancer and Challenges Ahead -- Chapter 8. Pancreatic Cancer Treatment by Using of Theranostics Nanoparticles -- Chapter 9. Nanomedicine Based Combinational Therapy for Breast Cancer -- Chapter 10. Nano-Liposomal System for Breast Cancer Therapy -- Chapter 11. Conventional to Nanotherapeutic Strategies against Triple-Negative Breast Cancer -- Chapter 12. Effect of Thymoquinone and Its Delivery Through Using of Nanomedicine in Benign Prostatic Hyperplasia -- Chapter 13. Concept of Nanotechnology in Management of Neuroendocrine Tumours -- Chapter 14. Neurocognitive Underpinning of Neurological Disorders: The Role of Default Mode Network -- Chapter 15. Neuroendocrine Carcinoma of The Endometrium: Conventional Treatment Approach to Nanomedicine -- Chapter 16. Effective Luteinizing Hormone Drug Delivery by Gold Nanoparticles in Hormonal Cancer Treatment -- Chapter 17. Regulatory Landscapes in Approval of Cancer Vaccines. |
| Record Nr. | UNINA-9910640388903321 |
| Singapore : , : Springer, , [2023] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
How to find a doctor or treatment facility if you have cancer [[electronic resource]]
| How to find a doctor or treatment facility if you have cancer [[electronic resource]] |
| Pubbl/distr/stampa | [Bethesda, Md.] : , : National Cancer Institute, , [2008] |
| Descrizione fisica | 12 pages : digital, PDF file |
| Collana | Fact sheet |
| Soggetto topico | Cancer - Treatment |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | How To Find a Doctor or Treatment Facility If You Have Cancer |
| Record Nr. | UNINA-9910698551703321 |
| [Bethesda, Md.] : , : National Cancer Institute, , [2008] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Hybrid nanostructures in cancer therapy [[electronic resource] /] / Mohsen Adeli, editor
| Hybrid nanostructures in cancer therapy [[electronic resource] /] / Mohsen Adeli, editor |
| Pubbl/distr/stampa | Hauppauge, N.Y., : Nova Science Publishers, c2012 |
| Descrizione fisica | 1 online resource (216 p.) |
| Disciplina | 616.99/4061 |
| Altri autori (Persone) | AdeliMohsen |
| Collana |
Cancer etiology, diagnosis and treatments
Nanotechnology science and technology |
| Soggetto topico |
Cancer - Treatment
Nanostructures - Therapeutic use |
| Soggetto genere / forma | Electronic books. |
| ISBN | 1-62100-558-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Hybrid nanostructures : promising drug delivery systems / Mohsen Adeli -- Biomedical applications of cyclodextrin-polymers / Mohsen Adeli and Mahdieh Kalantari -- Dendrimers and cancer therapy / Mohsen Adeli and Masoumeh Hamid -- Biomedical applications of carbon nanotubes supramolecules / Mohsen Adeli ... [et al.] -- Functionalized carbon nanotubes : new tools in nanomedicine / Mohsen Adeli and Masoumeh Bavadi -- Quantum dot-polymer hybrid nanomaterials in nanomedicine / Mohsen Adeli, Masoumeh Parsamanesh, and Elham Sadeghi -- Gold nanoparticle-polymer hybrid nanomaterials and biological applications / Mohsen Adeli, Fahimeh Madani, and Raziyeh Yadollahi -- Application of TiO2 nanomaterials for photocatalytic destruction of biological species and cancer therapy / Alireza Khataee and Mehrangiz Fathinia. |
| Record Nr. | UNINA-9910453791803321 |
| Hauppauge, N.Y., : Nova Science Publishers, c2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Hybrid nanostructures in cancer therapy [[electronic resource] /] / Mohsen Adeli, editor
| Hybrid nanostructures in cancer therapy [[electronic resource] /] / Mohsen Adeli, editor |
| Pubbl/distr/stampa | Hauppauge, N.Y., : Nova Science Publishers, c2012 |
| Descrizione fisica | 1 online resource (216 p.) |
| Disciplina | 616.99/4061 |
| Altri autori (Persone) | AdeliMohsen |
| Collana |
Cancer etiology, diagnosis and treatments
Nanotechnology science and technology |
| Soggetto topico |
Cancer - Treatment
Nanostructures - Therapeutic use |
| ISBN | 1-62100-558-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Hybrid nanostructures : promising drug delivery systems / Mohsen Adeli -- Biomedical applications of cyclodextrin-polymers / Mohsen Adeli and Mahdieh Kalantari -- Dendrimers and cancer therapy / Mohsen Adeli and Masoumeh Hamid -- Biomedical applications of carbon nanotubes supramolecules / Mohsen Adeli ... [et al.] -- Functionalized carbon nanotubes : new tools in nanomedicine / Mohsen Adeli and Masoumeh Bavadi -- Quantum dot-polymer hybrid nanomaterials in nanomedicine / Mohsen Adeli, Masoumeh Parsamanesh, and Elham Sadeghi -- Gold nanoparticle-polymer hybrid nanomaterials and biological applications / Mohsen Adeli, Fahimeh Madani, and Raziyeh Yadollahi -- Application of TiO2 nanomaterials for photocatalytic destruction of biological species and cancer therapy / Alireza Khataee and Mehrangiz Fathinia. |
| Record Nr. | UNINA-9910779787303321 |
| Hauppauge, N.Y., : Nova Science Publishers, c2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Hybrid nanostructures in cancer therapy [[electronic resource] /] / Mohsen Adeli, editor
| Hybrid nanostructures in cancer therapy [[electronic resource] /] / Mohsen Adeli, editor |
| Pubbl/distr/stampa | Hauppauge, N.Y., : Nova Science Publishers, c2012 |
| Descrizione fisica | 1 online resource (216 p.) |
| Disciplina | 616.99/4061 |
| Altri autori (Persone) | AdeliMohsen |
| Collana |
Cancer etiology, diagnosis and treatments
Nanotechnology science and technology |
| Soggetto topico |
Cancer - Treatment
Nanostructures - Therapeutic use |
| ISBN | 1-62100-558-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Hybrid nanostructures : promising drug delivery systems / Mohsen Adeli -- Biomedical applications of cyclodextrin-polymers / Mohsen Adeli and Mahdieh Kalantari -- Dendrimers and cancer therapy / Mohsen Adeli and Masoumeh Hamid -- Biomedical applications of carbon nanotubes supramolecules / Mohsen Adeli ... [et al.] -- Functionalized carbon nanotubes : new tools in nanomedicine / Mohsen Adeli and Masoumeh Bavadi -- Quantum dot-polymer hybrid nanomaterials in nanomedicine / Mohsen Adeli, Masoumeh Parsamanesh, and Elham Sadeghi -- Gold nanoparticle-polymer hybrid nanomaterials and biological applications / Mohsen Adeli, Fahimeh Madani, and Raziyeh Yadollahi -- Application of TiO2 nanomaterials for photocatalytic destruction of biological species and cancer therapy / Alireza Khataee and Mehrangiz Fathinia. |
| Record Nr. | UNINA-9910825978203321 |
| Hauppauge, N.Y., : Nova Science Publishers, c2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Hysterectomy : A Comprehensive Surgical Approach / / edited by Ibrahim Alkatout, Liselotte Mettler
| Hysterectomy : A Comprehensive Surgical Approach / / edited by Ibrahim Alkatout, Liselotte Mettler |
| Edizione | [1st ed. 2018.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2018 |
| Descrizione fisica | 1 online resource (XXXVII, 1639 p. 2299 illus., 2117 illus. in color.) |
| Disciplina | 618.1 |
| Soggetto topico |
Gynecology
Endoscopic surgery Cancer - Treatment Minimally Invasive Surgery Cancer Therapy |
| ISBN | 3-319-22497-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Part I. Historical Background -- 1. The History of Hysterectomy -- 2. History of Radical Hysterectomy -- Part II. Topographical Anatomy -- 3. Topographical Anatomy for Hysterectomy Procedures -- Part III. Imaging and Diagnostics -- 4. Clinical Diagnostics before Hysterectomy -- 5. Ultrasound imaging -- 6. Radio-imaging for benign uterine disease -- 7. Radio-imaging for malignant uterine disease -- 8. Interventional diagnostics before hysterectomy -- Part IV. Extended Aspects Regarding Indications and Contraindications -- 9. Evidence based review of Hysterectomy and Sexuality -- 10. Guidelines and recommendations of scientific societies and associations for hysterectomy -- 11. Choosing the Correct Hysterectomy Technique -- 12. Indications for Salpingectomy -- 13. Indications for oophorectomy and adnexectomy -- 14. Uterine sarcomas and atypical smooth-muscle tumors – clinic, diagnostics and appropriate surgical therapy -- 15. Uterine Morcellation -- Part V. Surgical Education and Training -- 16. Learning by doing: How to teach hysterectomy -- 17. Communicative and ethical aspects of the doctor-patient relationship in extreme situations -- Part VI. Macroscopic and Microscopic Pathological Aspects -- 18. Processing and histopathological workup of Hysterectomy specimens -- VII. Specific Hematological and Anesthesiological Aspects -- 19. Perioperative management of antithrombotic therapy in the periprocedural period of patients undergoing hysterectomy -- 20. Anaesthesia in Gynaecology -- Part VIII. Laparoscopic Hysterectomy and Extended Procedures for Benign and Malignant Indications -- 21. Indications and Contraindications for Laparoscopic Hysterectomy -- 22. Preparation (Medical History, Surgical Set-up, Antibiotics, Anticoagulants) -- 23. Instrumentation Systems, Apparatus and Materials in Hysterectomy -- 24. Uterine Manipulators for Total Laparoscopic Hysterectomy -- 25. Diagnostic laparoscopy and final site recognition -- 26. General Aspects and Their Handling: Adhesions -- 27. Comorbidities -- 28. General Surgery Conditions and Techniques for Gyne-Endoscopic Surgeons -- 29. Fibroids in laparoscopic hysterectomy.-30. Symptomatic fibroids as main indication for laparoscopic hysterectomy and their handling -- 31. Uterine-Preserving Operative Therapy of Uterus Myomatosus -- 32. Laparoscopic subtotal hysterectomy (LSH) -- 33. Laparoscopic supracervical hysterectomy for large uteri -- 34. Cervical Stump Extirpation -- 35. Total laparoscopic hysterectomy for the small and normal-sized uterus -- 36. Total Laparoscopic Hysterectomy in Patients with Bulky Uterus -- 37. Total Laparoscopic Hysterectomy for the Patient with Concomitant Pelvic Organ Pelvic Prolapse -- 38. Laparoscopic assisted vaginal hysterectomy in prolapse situations -- 39. Radical Hysterectomy and Pelvic Lymphadenectomy (French school) -- 40. Laparoscopic Radical Hysterectomy with Pelvic Lymphadenectomy (Spanish school) -- 41. Total laparoscopic nerve-sparing radical hysterectomy -- 42. Modified nerve-sparing radical-like hysterectomy for deep infiltrating endometriosis -- 43. Laparoscopic Total Mesometrial Resection (L-TMMR) -- 44. Laparoscopic radical hysterectomy for malignant indications:Laparoscopic trachelectomy -- 45. Laparoscopic radical hysterectomy with anterior and posterior exenteration - gynecological perspectives -- 46. Laparoscopic radical hysterectomy (LRH) with anterior and posterior exenteration -- 47. LRH with anterior and posterior exenteration: Surgical perspectives -- 48. Hysterectomy in the surgical management of endometriosis -- 49. Laparoscopic Hysterectomy (TLH) in obese patients -- 50. Laparoendoscopic Single-Site (LESS) Hysterectomy -- 51. Laparoscopic Pelvic and Paraaortic Lymphonodectomy -- 52. Surgical techniques of laparoscopic omentectomy -- 53. Final steps and postoperative considerations -- 54. Extraperitoneal hysterectomy- total pelvic peritonectomy combined with the segmental resection of the rectosigmoid -- Part IX. Robotic-assisted Laparoscopic Hysterectomy and Extended Procedures for Benign and Malignant Indication -- 55. Indications and Contraindications to Robotic-Assisted Hysterectomy -- 56. Preparation of Robotic-Assisted Laparoscopic Hysterectomy -- 57. Instruments, apparatuses and uterine manipulators for hysterectomy with special focus on robotic-assisted laparoscopic hysterectomy -- 58. Diagnostic laparoscopy via the Da Vinci robot in general and site recognition -- 59. General Aspects and their Handling: Adhesions -- 60. General Aspects and their Handling: Comorbidities -- 61. General aspects and their handling: General surgery conditions and techniques for robotic hysterectomy -- 62. Robotic assisted supracervical hysterectomy -- 63. Cervical stump extirpation with regard to robotic-assisted laparoscopic hysterectomy -- 64. Robotic-assisted total hysterectomy: Hysterectomy Techniques in the Normal-Sized and Small Uterus -- 65. Robotic-assisted total hysterectomy: Hysterectomy techniques for the large uterus -- 66. Robotic-assisted total hysterectomy: Hysterectomy techniques in prolapse situations -- 67. Robotic-assisted Radical Hysterectomy -- 68. Robotic-assisted radical hysterectomy (RRH) as nerve-sparing procedure -- 69. Robotic-assisted radical hysterectomy as compartmental resection according to rTMMR and rPMMR -- 70. Robotically assisted therapeutic pelvic and paraaortic lymphadenectomy in uterine cancer -- 71. Robot assisted laparoscopic fertility sparing radical trachelectomy -- 72. Robotic-Assisted Radical Hysterectomy with Anterior and Posterior Exenteration – Urological Perspectives -- 73. Robotic-assisted radical hysterectomy with anterior and posterior exenteration - Surgical perspective74. Robotic-Assisted Laparoscopic Hysterectomy and Endometriosis -- 75. Hysterectomy techniques for obese patients -- 76. Robotic-assisted single-port laparoscopic hysterectomy -- 77. Robot assisted laparoscopic pelvic and paraaortic -- lymphadenectomy -- 78. Techniques for Gastrocolic and Infracolic Robotic Omentectomy -- 79. Robotic-assisted Laparoscopic Hysterectomy: Final steps and postoperative considerations -- Part X. Abdominal Hysterectomy and Extended Procedures for Benign and Malignant Indications -- 80. Abdominal Hysterectomy: Indications and contraindications -- 81. Abdominal Hysterectomy: Preparation -- 82. Abdominal Hysterectomy: Instrumentation and Apparatuses -- 83. Midline Laparotomy -- 84. Transverse Incisions -- 85. Adhesions -- 86. Comorbidities and Abdominal Hysterectomy -- 87. Subtotal Abdominal Hysterectomy -- 88. Cervical Stump Extirpation.-89. Total abdominal hysterectomy in benign conditions: Hysterectomy techniques for the normal-sized and small uterus -- 90. Total Abdominal Hysterectomy in Benign Indications: Hysterectomy Techniques for the Large Uterus -- 91. Total abdominal hysterectomy in benign indications: Hysterectomy techniques for prolapse situations - Cervico-Sacropexy (CESA) and Cervico-Recto-Sacropexy (CERESA) -- 92. Total abdominal hysterectomy in benign indications: Hysterectomy techniques for prolapse situations - Vagino-Sacropexy (VASA) and Vagino-Recto-Sacropexy (VARESA) -- 93. Total abdominal hysterectomy in benign indications: Hysterectomy techniques for prolapse situations - Uterosacropexy and Uterorectosacropexy -- 94. Total Abdominal Hysterectomy with Electrosurgical Bipolar Vessel Sealing -- 95. Peripartum Hysterectomy -- 96. Abdominal Hysterectomy for obese patients -- 97. Wertheim-Meigs abdominal radical hysterectomy and lymphadenectomy -- 98. Okabayashi Radical Hysterectomy -- 99. Radical abdominal hysterectomy with electrosurgical bipolar vessel sealing -- 100. ARH as a Nerve-Sparing Procedure -- 101. Total and Peritoneal Mesometrial Resection -- 102. Radical abdominal trachelectomy -- 103. Radical Abdominal Hysterectomy with Anterior and Posterior Exenteration – Gynecological Perspectives -- 104. Radical abdominal hysterectomy with anterior exenteration: Urological Perspectives -- 105. Radical abdominal hysterectomy (RAH) with anterior and posterior exenteration: Surgical perspectives -- 106. Pelvic and para-aortic lymph node dissection -- 107. Omentectomy -- 108. Abdominal closure at longitudinal and horizontal abdominal incisions -- 109. Abdominal Hysterectomy: Postoperative care -- Part XI. Abdominal Hysterectomy and Extended Procedures for Benign and Malignant Indications -- 110. Indications and Contraindications of Vaginal Hysterectomy -- 111. Preparation for Vaginal Hysterectomy: history, preoperative assessment, operative set-up, table, antibiotics -- 112. Vaginal Hysterectomy: Instrumentation and Apparatuses -- 113. Colpotomy and the modalities for closure -- 114. Adhesions -- 115. Comorbidities associated with vaginal hysterectomy -- 116. Vaginal total hysterectomy in benign indications: Hysterectomy techniques in the normal-sized uterus -- 117. Hysterectomy Techniques for the Large Uterus -- 118. Vaginal total hysterectomy in benign indications: Hysterectomy techniques with bipolar diathermy system -- 119. The advantages in the selection and use of bipolar vessel sealing devices in vaginal hysterectomy, dependent on the different degrees of operative difficulty -- 120. Hysterectomy Techniques in Prolapse Situations -- 121. Trachelectomy: Removal of cervical stump following supracervical hysterectomy -- 122. Vaginal Salpingo-Oophorectomy -- 123. The Mayo Technique for Vaginal Hysterectomy -- 124. Vaginal-assisted laparoscopic radical hysterectomy and pelvic lymphadenectomy -- 125. Radical vaginal trachelectomy -- 126. Difficult Vaginal Hysterectomy -- 127. Hysterectomy in Women without Previous Vaginal Delivery -- 128. Vaginal Hysterectomy in the Obese Patient -- 129. Vaginal Cuff Dehiscence Following Hysterectomy -- 130. Postoperative care -- Part XII. Conservative Management -- 131. What is the place of myoma surgery with the advent of selective progesterone receptor modulators (SPRMs)? -- 132. Future Perspectives in Hysterec. |
| Record Nr. | UNINA-9910300314603321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2018 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
If you have cancer and have medicare... : you should know about clinical trials
| If you have cancer and have medicare... : you should know about clinical trials |
| Pubbl/distr/stampa | [Bethesda, Md.] : , : U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute, , 2009 |
| Descrizione fisica | 1 online resource (2 unnumbered pages) : color illustrations |
| Collana | NIH publication |
| Soggetto topico |
Cancer - Treatment
Medicare Clinical trials |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | If you have cancer and have medicare |
| Record Nr. | UNINA-9910698683803321 |
| [Bethesda, Md.] : , : U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute, , 2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Soggetto topico
-
Cancer - Treatment
(431)
- Cancer Therapy (60)
- Cancer (51)
- Neoplasms - therapy (47)
- Oncology (46)